These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 21620713

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.
    Vullo D, Voipio J, Innocenti A, Rivera C, Ranki H, Scozzafava A, Kaila K, Supuran CT.
    Bioorg Med Chem Lett; 2005 Feb 15; 15(4):971-6. PubMed ID: 15686895
    [Abstract] [Full Text] [Related]

  • 3. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.
    Güzel O, Innocenti A, Scozzafava A, Salman A, Supuran CT.
    Bioorg Med Chem; 2009 Jul 15; 17(14):4894-9. PubMed ID: 19539481
    [Abstract] [Full Text] [Related]

  • 4. Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies.
    Carta F, Garaj V, Maresca A, Wagner J, Avvaru BS, Robbins AH, Scozzafava A, McKenna R, Supuran CT.
    Bioorg Med Chem; 2011 May 15; 19(10):3105-19. PubMed ID: 21515057
    [Abstract] [Full Text] [Related]

  • 5. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib.
    Di Fiore A, Pedone C, D'Ambrosio K, Scozzafava A, De Simone G, Supuran CT.
    Bioorg Med Chem Lett; 2006 Jan 15; 16(2):437-42. PubMed ID: 16290146
    [Abstract] [Full Text] [Related]

  • 6. Carbonic anhydrase inhibitors. Phenacetyl-, pyridylacetyl- and thienylacetyl-substituted aromatic sulfonamides act as potent and selective isoform VII inhibitors.
    Güzel O, Innocenti A, Scozzafava A, Salman A, Supuran CT.
    Bioorg Med Chem Lett; 2009 Jun 15; 19(12):3170-3. PubMed ID: 19435663
    [Abstract] [Full Text] [Related]

  • 7. Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies.
    Güzel O, Temperini C, Innocenti A, Scozzafava A, Salman A, Supuran CT.
    Bioorg Med Chem Lett; 2008 Jan 01; 18(1):152-8. PubMed ID: 18024029
    [Abstract] [Full Text] [Related]

  • 8. Carbonic anhydrase inhibitors. Interaction of 2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies.
    Temperini C, Cecchi A, Boyle NA, Scozzafava A, Cabeza JE, Wentworth P, Blackburn GM, Supuran CT.
    Bioorg Med Chem Lett; 2008 Feb 01; 18(3):999-1005. PubMed ID: 18162396
    [Abstract] [Full Text] [Related]

  • 9. Carbonic anhydrase inhibitors. Sulfonamide diuretics revisited--old leads for new applications?
    Temperini C, Cecchi A, Scozzafava A, Supuran CT.
    Org Biomol Chem; 2008 Jul 21; 6(14):2499-506. PubMed ID: 18600270
    [Abstract] [Full Text] [Related]

  • 10. 4-[N-(substituted 4-pyrimidinyl)amino]benzenesulfonamides as inhibitors of carbonic anhydrase isozymes I, II, VII, and XIII.
    Sūdžius J, Baranauskienė L, Golovenko D, Matulienė J, Michailovienė V, Torresan J, Jachno J, Sukackaitė R, Manakova E, Gražulis S, Tumkevičius S, Matulis D.
    Bioorg Med Chem; 2010 Nov 01; 18(21):7413-21. PubMed ID: 20889345
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalimide moiety.
    Sethi KK, Vullo D, Verma SM, Tanç M, Carta F, Supuran CT.
    Bioorg Med Chem; 2013 Oct 01; 21(19):5973-82. PubMed ID: 23965175
    [Abstract] [Full Text] [Related]

  • 14. Tricyclic sulfonamides incorporating benzothiopyrano[4,3-c]pyrazole and pyridothiopyrano[4,3-c]pyrazole effectively inhibit α- and β-carbonic anhydrase: X-ray crystallography and solution investigations on 15 isoforms.
    Marini AM, Maresca A, Aggarwal M, Orlandini E, Nencetti S, Da Settimo F, Salerno S, Simorini F, La Motta C, Taliani S, Nuti E, Scozzafava A, McKenna R, Rossello A, Supuran CT.
    J Med Chem; 2012 Nov 26; 55(22):9619-29. PubMed ID: 23067387
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Designing of novel carbonic anhydrase inhibitors and activators.
    Supuran CT, Vullo D, Manole G, Casini A, Scozzafava A.
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan 26; 2(1):49-68. PubMed ID: 15328829
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
    Saczewski F, Innocenti A, Sławiński J, Kornicka A, Brzozowski Z, Pomarnacka E, Scozzafava A, Temperini C, Supuran CT.
    Bioorg Med Chem; 2008 Apr 01; 16(7):3933-40. PubMed ID: 18242998
    [Abstract] [Full Text] [Related]

  • 20. Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.
    Nishimori I, Vullo D, Minakuchi T, Morimoto K, Onishi S, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2006 Apr 15; 16(8):2182-8. PubMed ID: 16459077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.